Feedback

Editorial: Novel biomarkers for anticancer therapy

Affiliation
Department of Clinical Research ,Sichuan Cancer Hospital and Institution ,Sichuan Cancer Center ,School of Medicine ,University of Electronic Science and Technology of China ,Chengdu ,China
Wang, Ting;
Affiliation
Department of Pharmaceutical Sciences ,College of Pharmacy and Health Sciences ,St. John’s University ,Queens ,NYC ,United States
Chen, Zhe-Sheng;
Affiliation
Department of Pharmacy ,Union Hospital ,Tongji Medical College ,Huazhong University of Science and Technology (HUST) ,Wuhan ,China
Shi, Chen;
Affiliation
State Key Laboratory of Biotherapy ,Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer ,West China Hospital ,Sichuan University ,Chengdu ,China
Ouyang, Liang;
Affiliation
Department of Pharmacy ,Sichuan Cancer Hospital and Institution ,Sichuan Cancer Center ,School of Medicine ,University of Electronic Science and Technology of China ,Chengdu ,China
Xiao, Hongtao

Preview

Category

Published in:
Frontiers in Pharmacology
Vol. 13 (06.01.2023)
Volume:
13
Date Issued:
06.01.2023
DOI:
10.3389/fphar.2022.1109761
Language:
English
Type of Resource:
Text
Keywords:
biomarker; anticancer; non-coding RNAs; chemoresisitance; gene mutation; metabolic reprogramming
DDC subject of DNB:
610 Medical sciences Medicine

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:
open graphic

Rights

License Holder: Copyright © 2023 Wang, Chen, Shi, Ouyang and Xiao.

Use and reproduction: